Unusual options activity at Pfizer Inc. (PFE)
Today, December 31, 2021, among the underlying constituents of the NYSE, we saw unusual or noticeable options trading volume and activity at Pfizer Inc. (PFE), which opened at $ 58.53.
- There were 1,541 contracts traded on the $ 60 exercise call option dated January 7, 2021
- Open interest on this channel was 11,600 at this morning’s opening, and with this new volume, the total channel volume exceeded open interest, by 12,195 to 11,596, respectively.
- Additionally, Pfizer Inc.’s option order flow put-call ratio is 0.6, implying that the uptrend is increasing.
- A flow advice: The put / call ratio (P / C) is the put volume divided by the call volume. The put / call ratio is important and can be an indication of a change in sentiment. AP / C above 0.7 means more puts are bought than calls, so the trend turns bearish. AP / C from 0.7 to 0.5 becomes more bullish
Above are all of Pfizer Inc.’s notable options from the Unusual Whales workflow tool.
The orders come after the UK approved Pfizer’s Covid-19 antiviral pill “Paxlovid”.
Above is the historical volume of the aforementioned chain, in red, and open interest, in blue, as bar charts behind required supply and demand, in a light blue and darker tint, respectively .
Historically, this chain saw its spot price peak around December 16 and 17, and today hit its highest volumes and open interest so far as supply-demand starts to climb again.
To view more information on the daily breakdown of PFE flows, click here to visit unusualwhales.com.
A review of unusual options activity in ZoomInfo Technologies Inc. (ZI)
Yesterday December 30, 2021, in the market capitalization weighted index NASDAQ Global Select Market Composite (NasdaqGS), we have seen reports of unusual or noteworthy options trading volume and activity in ZoomInfo Technologies Inc. (ZI), which opened then at $ 64.86 and today at $ 64.43.
- There were 4,000 contracts traded on the $ 70 exercise call option, dated January 21, 2022
- In addition, 2,500 contracts were traded on the $ 65 exercise call option, for the same date
- It should be noted that the open interest on the $ 65 strike call was higher than this channel’s volume
Above you see all of ZoomInfo Technologies Inc.’s remarkable options from the Unusual Whales Feed Tool.
These are the orders that arrived yesterday just before closing (please note, the timestamps were in a different time zone; this would have been around 3:50 p.m. EST).
As stated, on the $ 65 call option the volume for the day was about the size of this order, but the open interest was around 3,800 … so at that time, there was simply no way of knowing if they had been bought or sold open.
However, the $ 70 call option contracts were well above the 2,900 open interest, so we can be sure they were bought or sold to open.
- A tip from the flow: Transactions marked with 🛍️ can be intuitively bought or sold to open. This determination is made if the size of the trade was greater than the open interest of the chain.
- Only transactions that can be positively identified as being bought or sold at the opening will be marked as such (with the symbol 🛍️)
- Be aware! Transactions without the 🛍️ symbol could still have been bought or sold to open!
Above is the volume and open interest, highlighted in pink, for the $ 70 exercise call option dated January 21, 2021.
As of today’s opening, open interest on the channel has increased by about 4,000 from yesterday, implying that Whale has in fact entered into the $ 70 strike call contracts. to open.
Above is the volume and open interest, highlighted in pink, for the $ 65 exercise call option dated January 21, 2021.
As of today’s opening, open interest on the $ 65 strike chain decreases, which implies that the whale got out these orders yesterday.
In total, therefore, this whale extended its $ 65 exercise option contracts and wrote more contracts, thus increasing the scale of this bet overall.
To view more information on ZI’s feed breakdown, click here to visit unusualwhales.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.